Literature DB >> 25573681

Cytologic and functional alterations of nasal mucosa in smokers: temporary or permanent damage?

Giulio Pagliuca1, Chiara Rosato2, Salvatore Martellucci2, Marco de Vincentiis3, Antonio Greco3, Massimo Fusconi3, Armando De Virgilio3, Camilla Gallipoli2, Marilia Simonelli4, Andrea Gallo2.   

Abstract

OBJECTIVE: Tobacco smoke is a significant risk factor for respiratory diseases. The purpose of this study is to analyze the cytologic and functional features of nasal mucosa in smokers, nonsmokers, and ex-smokers to evaluate if nasal alterations in smokers are permanent or reversible conditions after smoking cessation. STUDY
DESIGN: Case series with planned data collection.
SETTING: University medical center. SUBJECTS AND METHODS: Ninety healthy volunteers recruited from the staff of Alfredo Fiorini Hospital, Sapienza University of Rome, were enrolled in this prospective study from October to November 2013. We divided the cases according to smoking habits (smokers, nonsmokers, ex-smokers). Each group was composed of 30 subjects. Cytologic features of nasal mucosa and effectiveness of nasal mucociliary clearance were studied, focusing on 4 parameters: (1) nasal mucociliary clearance, assessed by saccharin nasal transit time; (2) ratio between the number of ciliated cells and goblet cells, analyzed by microscopic observation of cytologic specimens of nasal mucosa that had undergone May Grunwald Giemsa staining; (3) evaluation of ciliary motility; and (4) time of ciliary movement of ciliated cells analyzed by phase-contrast microscopy.
RESULTS: All parameters were significantly reduced in the smokers compared to the nonsmokers. There were no statistically significant differences between the nonsmoker and ex-smoker groups.
CONCLUSION: Cigarette smoking causes cytologic modifications of nasal mucosa that influence the effectiveness of mucociliary clearance. Our preliminary study suggests that these changes are not permanent and that nasal mucosa of ex-smokers recovers normal cytologic and functional features. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  mucociliary clearance; nasal cytology; phase-contrast microscopy; smoke

Mesh:

Year:  2015        PMID: 25573681     DOI: 10.1177/0194599814566598

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  The effect of tobacco smoking on septoplasty outcomes: a prospective controlled study.

Authors:  Z M Yazici; I Sayin; I Erdim; S Gunes; F T Kayhan
Journal:  Hippokratia       Date:  2015 Jul-Sep       Impact factor: 0.471

2.  Laryngotracheal Stenosis: Risk Factors for Tracheostomy Dependence and Dilation Interval

Authors:  Shekhar K Gadkaree; Vinciya Pandian; Simon Best; Kevin M Motz; Clint Allen; Young Kim; Lee Akst; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2016-10-26       Impact factor: 3.497

3.  Impact of exclusive e-cigarettes and heated tobacco products use on muco-ciliary clearance.

Authors:  R Polosa; R Emma; F Cibella; M Caruso; G Conte; F Benfatto; S Ferlito; A Gulino; M Malerba; P Caponnetto
Journal:  Ther Adv Chronic Dis       Date:  2021-08-12       Impact factor: 5.091

4.  The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation.

Authors:  Daniela Mitiyo Odagiri Utiyama; Carolina Tieko Yoshida; Danielle Miyuki Goto; Tômas de Santana Carvalho; Ubiratan de Paula Santos; Andreas Rembert Koczulla; Paulo Hilário Nascimento Saldiva; Naomi Kondo Nakagawa
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

Review 5.  Aeroallergens, air pollutants, and chronic rhinitis and rhinosinusitis.

Authors:  Nyall R London; Ioan Lina; Murugappan Ramanathan
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-11-10

6.  Examining the evidence for the health impact of combustion-free products: progress and prospects for tobacco harm reversal and reduction.

Authors:  Riccardo Polosa
Journal:  Intern Emerg Med       Date:  2021-09-15       Impact factor: 3.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.